AKT1 and glioma: To obtain direct evidence for the involvement of the RAS-RAF-MEK-ERK and PI3K-AKT/PKB-mTOR pathways in increasing the resistance of gliomas to the induction of programmed cell death by chemotherapeutics, we blocked the expression of RAF and PI3K kinases by specific siRNAs.